Eyelid Carcinoma (SGC): A Tool To Predict Recurrence

Eyelid Carcinoma (SGC): A Tool To Predict Recurrence Overview Eyelid sebaceous gland carcinoma (SGC) is a highly malignant condition with a significant recurrence risk. This study aimed to create a predictive nomogram for SGC recurrence based on risk factors.   A retrospective study involving 391 patients from one hospital (304) and grassroots hospitals (87)

Eyelid Rhabdomyosarcoma Survival In Children’s Oncology

Eyelid Rhabdomyosarcoma Survival In Children's Oncology Overview Survival outcomes in Orbital Rhabdomyosarcoma (ORMS) typically show excellent results, especially in low-risk cases (stage 1, group I-III, embryonal RMS). However, long-term follow-up data on low-risk ORMS and less common subgroups treated in recent Children's Oncology Group (COG) trials were previously unreported. To fill this

Eyelid Carcinoma (SGC): A Tool To Predict Recurrence